SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by US Bancorp DE

US Bancorp DE cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,980 shares of the exchange traded fund’s stock after selling 190 shares during the quarter. US Bancorp DE’s holdings in SPDR S&P Biotech ETF were worth $539,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Golden State Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $29,000. Avior Wealth Management LLC lifted its position in shares of SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC grew its stake in shares of SPDR S&P Biotech ETF by 101.5% during the third quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. Bank of Jackson Hole Trust purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at $43,000. Finally, Howe & Rusling Inc. acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at $49,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $86.17 on Wednesday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock has a market cap of $5.68 billion, a P/E ratio of 11.47 and a beta of 0.93. The stock has a 50-day simple moving average of $90.34 and a 200-day simple moving average of $95.08.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.